View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Gastroenterology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 14, 2024
6 min watch
Save

VIDEO: Lifetime disruptor ‘just getting started’ in quest to elevate care for IBD patients

VIDEO: Lifetime disruptor ‘just getting started’ in quest to elevate care for IBD patients

Marla C. Dubinsky, MD, winner of the 2023 Healio Lifetime Disruptor Award, was first inspired to “disrupt the space” after witnessing patients with inflammatory bowel disease become frustrated with lack of support and access to care.

SPONSORED CONTENT
June 13, 2024
2 min read
Save

'Our patients deserve better': AMA adopts policies to protect health care access

'Our patients deserve better': AMA adopts policies to protect health care access

The AMA adopted policies to protect patients’ access to necessary health care in a variety of ways at its annual meeting.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
June 13, 2024
2 min read
Save

Hot flash severity may predict metabolic-associated liver disease

Hot flash severity may predict metabolic-associated liver disease

BOSTON — Midlife women reporting bothersome hot flashes are more likely to receive a diagnosis of metabolic dysfunction-associated steatotic liver disease regardless of hormone therapy use, according to a speaker.

SPONSORED CONTENT
June 13, 2024
1 min read
Save

AGA recommends endoscopic eradication vs. surveillance for BE with high-grade dysplasia

AGA recommends endoscopic eradication vs. surveillance for BE with high-grade dysplasia

In a new clinical practice guideline, the AGA provides evidence-based recommendations for use of endoscopic eradication therapy in the management of Barrett’s esophagus, accounting for the presence of dysplasia and other scenarios.

SPONSORED CONTENT
June 13, 2024
2 min watch
Save

VIDEO: Studies show no increased risk of cancer, CV events with JAK inhibitors

VIDEO: Studies show no increased risk of cancer, CV events with JAK inhibitors

In this video, Raymond Cross, MD, spoke with Healio about several studies assessing the safety and efficacy of JAK inhibitors in patients with IBD presented at Digestive Disease Week 2024.

SPONSORED CONTENT
June 12, 2024
2 min read
Save

Bulevirtide monotherapy ‘may prevent decompensation but not HCC’ in HDV, cirrhosis

Bulevirtide monotherapy ‘may prevent decompensation but not HCC’ in HDV, cirrhosis

Over 2 years, bulevirtide monotherapy reduced the risk for decompensation and mortality, but not hepatocellular carcinoma, among patients with hepatitis D virus and compensated cirrhosis compared with untreated patients.

SPONSORED CONTENT
June 12, 2024
2 min read
Save

AMA adopts policy advocating for Medicaid expansion

AMA adopts policy advocating for Medicaid expansion

The AMA adopted new policies on broader Medicare and Medicaid health care coverage during its annual House of Delegates meeting.

SPONSORED CONTENT
June 12, 2024
2 min read
Save

AMA: Drug, device sponsors need to include women, LGBTQ+ patients in trials

AMA: Drug, device sponsors need to include women, LGBTQ+ patients in trials

The AMA announced a new policy that supports requirements for drug and device sponsors to develop diversity action plans so that women and sexual and gender minorities are adequately represented in their clinical trials.

SPONSORED CONTENT
June 12, 2024
2 min read
Save

MASH patients with high BMI, weight respond ‘slightly better’ to higher Rezdiffra dose

MASH patients with high BMI, weight respond ‘slightly better’ to higher Rezdiffra dose

Patients with metabolic dysfunction-associated steatohepatitis who weigh more than 100 kg or a BMI more than 35 kg/m² had “slightly better” response with a 100 mg dose of Rezdiffra, according to data presented at EASL Congress.

SPONSORED CONTENT
June 12, 2024
2 min read
Save

Extensive psoriasis, IBD history predict difficult-to-treat psoriatic arthritis

Extensive psoriasis, IBD history predict difficult-to-treat psoriatic arthritis

Difficult-to-treat psoriatic arthritis was common in a large, real-life cohort, with key risk factors including extensive psoriasis, higher BMI and a history of inflammatory bowel disease, according to data published in Rheumatology.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails